臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

About TAIR
	About TAIR

Browse By
	Institution
	Author
	Title
	Date
	Statistics Chart
	Institution Facts
	Trend

News
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

Copyright
	Publisher & Journal Policy
	TAIR Copyright Conference Minutes

Related Links
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"jia horng kao"

Return to Browse by Author
Sorting by Title	Sort by Date

Showing items 556-580 of 1180 (48 Page(s) Totally)
<< < 18 19 20 21 22 23 24 25 26 27 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2021-09-04T05:17:11Z	Highlights	JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:17:11Z	Preface	JIA-HORNG KAO; Chen D.-S.
臺大學術典藏	2021-09-04T05:17:10Z	Highlights	JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:17:10Z	Hepatitis b virus–specific t cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation	Rivino L.; Le Bert N.; Gill U.S.; Kunasegaran K.; Cheng Y.; Tan D.Z.M.; Becht E.; Hansi N.K.; Foster G.R.; Su T.-H.; Tseng T.-C.; Lim S.G.; JIA-HORNG KAO; Newell E.W.; Kennedy P.T.F.; Bertoletti A.
臺大學術典藏	2021-09-04T05:17:10Z	Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection	Liu C.-H.; Chen Y.-S.; Wang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:17:09Z	Prevention of mother-to-child transmission: the key of hepatitis B virus elimination	Lin C.-L.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:17:09Z	Highlights	JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:17:09Z	Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan	Liu C.-H.; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:17:08Z	Highlights	JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:17:08Z	HCC risk in patients with HBV-related cirrhosis receiving nucleos(t)ide analogues therapy: Is HCC prevented or delayed?	Su T.-H.; Tseng T.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:17:08Z	Highlights	JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:17:08Z	Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir Therapy	Su T.-H.; Yang H.-C.; Tseng T.-C.; Liou J.-M.; Liu C.-H.; Chen C.-L.; Chen P.-J.; Chen D.-S.; Liu C.-J.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:17:07Z	Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan	Hsieh M.-H.; Yeh M.-L.; Su T.-H.; Liu T.-W.; Huang C.-F.; Huang C.-I.; Wang S.-C.; Huang J.-F.; Dai C.-Y.; JIA-HORNG KAO; Chuang W.-L.; Chen P.-J.; Liu C.-J.; Yu M.-L.
臺大學術典藏	2021-09-04T05:17:07Z	Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection	Tseng T.-C.; Liu C.-J.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:17:06Z	The effect of interferon-free regimens on health-related quality of life in East Asian patients with chronic hepatitis C	Younossi Z.M.; Stepanova M.; Henry L.; Han K.-H.; Ahn S.H.; Lim Y.-S.; Chuang W.-L.; JIA-HORNG KAO; Kinh N.; Lai C.L.; Yuen M.-F.; Chan H.L.-Y.; Lai W.
臺大學術典藏	2021-09-04T05:17:06Z	Highlights	JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:17:06Z	Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection	Liu C.-H.; Sun H.-Y.; Liu C.-J.; Sheng W.-H.; Hsieh S.-M.; Lo Y.-C.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:17:05Z	Acoustic radiation force impulse US imaging: Liver stiffness in patients with chronic hepatitis B with and without antiviral therapy	Su T.-H.; Liao C.-H.; Liu C.-H.; Huang K.-W.; Tseng T.-C.; Yang H.-C.; Liu C.-J.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:17:05Z	Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B	Hsu C.-W.; Su W.-W.; Lee C.-M.; Peng C.-Y.; Chuang W.-L.; JIA-HORNG KAO; Chu H.-C.; Huang Y.-H.; Chien R.-N.; Liaw Y.-F.
臺大學術典藏	2021-09-04T05:17:05Z	Highlights	JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:17:05Z	Review article: the prevention of hepatitis B-related hepatocellular carcinoma	Lin C.-L.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:17:04Z	Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis B	Papatheodoridis G.V.; Manolakopoulos S.; Su T.-H.; Siakavellas S.; Liu C.-J.; Kourikou A.; Yang H.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:17:04Z	Twelve-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin for non-cirrhotic HCV genotype 1 patients: A phase 2 study	JIA-HORNG KAO; Yu M.-L.; Chen C.-Y.; Peng C.-Y.; Chen M.-Y.; Tang H.; Chen Q.; Wu J.J.
臺大學術典藏	2021-09-04T05:17:04Z	Highlights	JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:17:03Z	Hepatitis B: From control to cure	JIA-HORNG KAO

Showing items 556-580 of 1180 (48 Page(s) Totally)
<< < 18 19 20 21 22 23 24 25 26 27 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| Total items :0
	Visitors : 51502232 Online Users : 678 Project Commissioned by the Ministry of Education Project Executed by National Taiwan University Library